George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...

WASHINGTON — President Trump said Sunday that he planned to help the creator of the satirical comic strip “Dilbert” get access to a prostate cancer drug.

This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...

Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...

Health care has become a central issue in this year’s elections, a sign of parties' midterm strategies to come.

NIH-led research on structural racism was published Friday, even as the Trump administration has cancelled and discredited ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

The crises at the heart of the government shutdown fight in Washington were coming to a head Saturday as the federal food assistance ...

Officials from Colorado, Illinois, Oregon, and Washington say CMS Administrator Mehmet Oz posted incorrect figures about their Medicaid spending on X.

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

Medicare on Friday followed through with its earlier proposal to reduce payment for surgeries, outpatient procedures, and other services it believes can be done more efficiently starting in 2026.

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse than Covid,” says global health expert Seth Berkley.